Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonardo Magro

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Joint Bone Spine|March 8, 2022
Changes in bone mineral density after allogenic stem cell transplantationDiane Leguy, Leonardo Magro, Adeline Pierache, et al.
Annals of Surgery|August 3, 2021
Diverting Enterostomy Improves Overall Survival of Patients With Severe Steroid-refractory Gastrointestinal Acute Graft-Versus-Host DiseaseJustine Khodr, Philippe Zerbib, Moshe Rogosnitzky, et al.
Infectious Disorders Drug Targets|April 8, 2016
Severe Adenovirus Pneumonia Followed by Bacterial Septicaemia: Relevance of Co-Infections in Allogeneic Hematopoietic Stem Cell TransplantationIlka Engelmann, Valerie Coiteux, Albert Heim, et al.
Bulletin Du Cancer|November 6, 2018
[Post-transplant neurological complications: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)]Yosr Hicheri, Nimrod Buchbinder, Leonardo Magro, et al.
Current Research in Translational Medicine|October 22, 2019
The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host diseaseTamim Alsuliman, Leonardo Magro, Valerie Coiteux, et al.
Bulletin Du Cancer|May 11, 2023
[Allogeneic hematopoietic stem cell transplantation and treatment with CAR-T cells - identification of psycho-social vulnerability factors: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Alice Polomeni, Malika Ainaoui, Aurélie Berr, et al.
Blood|March 18, 2009
Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host diseaseLeonardo Magro, Mohamad Mohty, Benoit Catteau, et al.
Bulletin Du Cancer|December 13, 2024
[Medical simulation training for bone marrow harvesting from a healthy donor for an allogeneic hematopoietic cell transplant (SFGM-TC)]Tamim Alsuliman, Leonardo Magro, Marie Titecat, et al.
Bulletin Du Cancer|September 6, 2024
[Place of hematopoietic stem cell transplantation for very high risk acute myeloblastic leukemia and myelodysplastic syndromes (SFGM-TC)]Clémence Mediavilla, Maud D'Aveni, Anne Huynh, et al.
Bulletin Du Cancer|November 28, 2017
[Management of the chronic graft versus host disease: Guidelines from the Francophone society of bone marrow transplantation and cellular therapies (SFGM-TC)]Leonardo Magro, Edouard Forcade, Christine Giraud, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Joint Bone Spine|March 8, 2022
Changes in bone mineral density after allogenic stem cell transplantationDiane Leguy, Leonardo Magro, Adeline Pierache, et al.
Annals of Surgery|August 3, 2021
Diverting Enterostomy Improves Overall Survival of Patients With Severe Steroid-refractory Gastrointestinal Acute Graft-Versus-Host DiseaseJustine Khodr, Philippe Zerbib, Moshe Rogosnitzky, et al.
Infectious Disorders Drug Targets|April 8, 2016
Severe Adenovirus Pneumonia Followed by Bacterial Septicaemia: Relevance of Co-Infections in Allogeneic Hematopoietic Stem Cell TransplantationIlka Engelmann, Valerie Coiteux, Albert Heim, et al.
Bulletin Du Cancer|November 6, 2018
[Post-transplant neurological complications: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)]Yosr Hicheri, Nimrod Buchbinder, Leonardo Magro, et al.
Current Research in Translational Medicine|October 22, 2019
The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host diseaseTamim Alsuliman, Leonardo Magro, Valerie Coiteux, et al.
Bulletin Du Cancer|May 11, 2023
[Allogeneic hematopoietic stem cell transplantation and treatment with CAR-T cells - identification of psycho-social vulnerability factors: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Alice Polomeni, Malika Ainaoui, Aurélie Berr, et al.
Blood|March 18, 2009
Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host diseaseLeonardo Magro, Mohamad Mohty, Benoit Catteau, et al.
Bulletin Du Cancer|December 13, 2024
[Medical simulation training for bone marrow harvesting from a healthy donor for an allogeneic hematopoietic cell transplant (SFGM-TC)]Tamim Alsuliman, Leonardo Magro, Marie Titecat, et al.
Bulletin Du Cancer|September 6, 2024
[Place of hematopoietic stem cell transplantation for very high risk acute myeloblastic leukemia and myelodysplastic syndromes (SFGM-TC)]Clémence Mediavilla, Maud D'Aveni, Anne Huynh, et al.
Bulletin Du Cancer|November 28, 2017
[Management of the chronic graft versus host disease: Guidelines from the Francophone society of bone marrow transplantation and cellular therapies (SFGM-TC)]Leonardo Magro, Edouard Forcade, Christine Giraud, et al.
Pageof 5